apuzzo michael (39 Ergebnisse)

Paperback. Zustand: Brand New. 100 pages. 8.50x0.24x5.50 inches. In Stock.

226 figs. in 391 separate ills., 25 in color, 80 tab., X, 640 p. Softcover Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Medical Radiology. Radiation Oncology. Sprache: Englisch.

Zustand: Very Good. Prompt Shipment, shipped in Boxes, Tracking PROVIDEDPart I only. Small tear to edge of front cover else very good. *.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Good. Most items will be dispatched the same or the next working day. A copy that has been read but remains in clean condition. All of the pages are intact and the cover is intact and the spine may show signs of wear. The book may have minor markings which are not specifically mentioned.

Lex. 8° (25-30 cm), Softcover. 2003. 226 Fig. in 391 sep. iIllustr., 25 in Color & 80 Tab.; 640 S. very good condition. Cover & pages without marks. --- The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued. 9783540006275 Sprache: Englisch Gewicht in Gramm: 1567.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: Used.

Zustand: Used.

Hardcover. Zustand: Brand New. 460 pages. 6.30x1.10x9.45 inches. In Stock.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Hervorragend. Zustand: Hervorragend | Seiten: 100 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Zustand: New.

Zustand: NEW.

Gebunden. Zustand: New. Benign Cerebral Glioma - Volume II synthesizes the considerable amount of information on the classic and evolving tools in the clinical treatment of these neoplasms. The text also presents practical guidelines for contemporary clinical management with the f.

Zustand: New.

Hardcover. Zustand: Brand New. 450 pages. 9.25x7.50x0.94 inches. In Stock.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Hardcover. Zustand: Brand New. 460 pages. 6.30x1.10x9.45 inches. In Stock.

Zustand: New. 2002. Illustrated. hardcover. . . . . . Books ship from the US and Ireland.

Zustand: Gut. Zustand: Gut | Seiten: 656 | Sprache: Englisch | Produktart: Bücher | The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.

Zustand: Hervorragend. Zustand: Hervorragend | Seiten: 656 | Sprache: Englisch | Produktart: Bücher | The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.

Buch. Zustand: Neu. Neuware - Benign Cerebral Glioma - Volume II synthesizes the considerable amount of information on the classic and evolving tools in the clinical treatment of these neoplasms. The text also presents practical guidelines for contemporary clinical management with the framework of currently available knowledge.Volume II discusses the clinical aspects of benign gliomas, including:Congential syndromes associated with benign gliomasImaging featuresThe role of stereotaxis in the management of low-grade intracranial gliomasRadiotherapeutic aspectsApplication of focused beam principlesEplipesy and benign gliomasSurgical aspects and general management of astrocytomas, oligodendrogliomas, ependymomas, and ganglion cell tumors.

Buch. Zustand: Neu. Neuware - Neurosurgery is seen as 'inaccessible' to those on the outside, even though collaboration with a variety of non-neurosurgeons is essential to advancing the field. Thus, this book answers important questions for those interested in surgery of the brain: What is the current state of affairs Where is the field going And, importantly, how can I be involved A work of far-reaching appeal, this book explores the evolution and future of brain surgery, detailing key technologies that have and will shape the field of neurosurgery. Readers are led on a journey covering over five thousand years of neurosurgical history, from trepanation in Neolithic France to the understanding of neuroanatomy and finally the technological leaps in the 20th and 21st centuries. Advances such as artificial intelligence, nanotechnology, microscopy, robotics are discussed by the world's leading experts, providing non-neurosurgical readers with a framework for how they can be involved in this thrilling field.

Zustand: New. Redaktion: Philip E. StiegDr. Philip Stieg is a world-renowned neurosurgeon with expertise in cerebrovascular disorders and skull base surgery. He is the chairman and founder of the Weill Cornell Medicine Brain and Spine Center, the leading neurosc.

Paperback. Zustand: Sehr gut. Gebraucht - Sehr gut Sg - leichte Beschädigungen oder Verschmutzungen, ungelesenes Mängelexemplar, gestempelt - The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.

Taschenbuch. Zustand: Neu. Neuware -The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 656 pp. Englisch.

Buch. Zustand: Neu. Neuware -The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 656 pp. Englisch.

Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.